Literature DB >> 25616706

Prevalence of type 2 diabetes is higher in peripheral artery disease than in coronary artery disease patients.

Guenther Silbernagel1, Philipp Rein2, Christoph H Saely2, Rolf P Engelberger3, Torsten Willenberg3, Dai-Do Do3, Nils Kucher3, Iris Baumgartner3, Heinz Drexel4.   

Abstract

Type 2 diabetes mellitus and pre-diabetes are risk factors for atherosclerosis and are highly prevalent in patients with coronary artery disease. However, the prevalence of impaired glucose metabolism in patients with peripheral artery disease is not as well elucidated. We aimed at comparing prevalence rates of type 2 diabetes mellitus and pre-diabetes, which were diagnosed according to the current American Diabetes Association criteria, among 364 patients with peripheral artery disease, 529 patients with coronary artery disease and 383 controls. The prevalence of type 2 diabetes mellitus in peripheral artery disease patients was 49.7%. It was significantly higher in these patients than in coronary artery disease patients (34.4%; p < 0.001) and controls (21.4%; p < 0.001). Adjusted for sex, age and body mass index, odds ratios for type 2 diabetes mellitus were 2.0 (95% confidence interval 1.5-2.6) comparing the peripheral artery disease group with the coronary artery disease group (p < 0.001) and 4.0 (2.8-5.8) comparing the peripheral artery disease group with controls (p < 0.001). The prevalence of pre-diabetes among non-diabetic subjects was high in all three study groups (64.5% in peripheral artery disease patients, 63.4% in coronary artery disease patients and 61.8% in controls), without significant between-group differences. In conclusion, the prevalence of type 2 diabetes mellitus is even higher in peripheral artery disease patients than in coronary artery disease patients. This observation underlines the need to consider impaired glucose regulation in the management of peripheral artery disease.
© The Author(s) 2015.

Entities:  

Keywords:  Coronary artery disease; glycated haemoglobin; oral glucose tolerance test; peripheral vascular disease; type 2 diabetes mellitus

Mesh:

Substances:

Year:  2015        PMID: 25616706     DOI: 10.1177/1479164114560342

Source DB:  PubMed          Journal:  Diab Vasc Dis Res        ISSN: 1479-1641            Impact factor:   3.291


  7 in total

1.  Lower Limb Amputation in Germany.

Authors:  Knut Kröger; Christian Berg; Frans Santosa; Nasser Malyar; Holger Reinecke
Journal:  Dtsch Arztebl Int       Date:  2017-02-24       Impact factor: 5.594

2.  The association of endothelial progenitor cell markers with arteriovenous fistula maturation in hemodialysis patients.

Authors:  Eray Eroglu; Ismail Kocyigit; Berkay Saraymen; Aydin Tuncay; Ertugrul Mavili; Aydin Unal; Huseyin Avcilar; Mustafa Yavuz Koker; Oktay Oymak
Journal:  Int Urol Nephrol       Date:  2016-04-11       Impact factor: 2.370

3.  The heart matters in diabetes: 10-Year outcomes of peripheral artery disease.

Authors:  Thomas Mueller; Franz Hinterreiter; Werner Poelz; Meinhard Haltmayer; Benjamin Dieplinger
Journal:  SAGE Open Med       Date:  2017-11-13

4.  Peripheral arterial disease and type 2 diabetes: Older patients still exhibit a survival benefit from glucose control.

Authors:  Clemens Höbaus; Carsten Thilo Herz; Thomas Wrba; Renate Koppensteiner; Gerit-Holger Schernthaner
Journal:  Diab Vasc Dis Res       Date:  2020 Mar-Apr       Impact factor: 3.291

5.  Type 2 diabetes and the risk of cardiovascular events in peripheral artery disease versus coronary artery disease.

Authors:  Lukas Sprenger; Arthur Mader; Barbara Larcher; Maximilian Mächler; Alexander Vonbank; Daniela Zanolin-Purin; Andreas Leiherer; Axel Muendlein; Heinz Drexel; Christoph H Saely
Journal:  BMJ Open Diabetes Res Care       Date:  2021-11

6.  Combination of the ankle-brachial index and percentage of mean arterial pressure to improve diagnostic sensitivity for peripheral artery disease: An observational study.

Authors:  Han-Wei Lin; I-Te Lee
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.889

7.  Cardiovascular efficacy of liraglutide and semaglutide in individuals with diabetes and peripheral artery disease.

Authors:  Subodh Verma; Mohammed Al-Omran; Lawrence A Leiter; C David Mazer; Søren Rasmussen; Hans A Saevereid; Maria Sejersten Ripa; Marc P Bonaca
Journal:  Diabetes Obes Metab       Date:  2022-04-11       Impact factor: 6.408

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.